EXCEPTIONS TO MEDAREX REPRESENTATIONS AND WARRANTIES Sample Clauses

EXCEPTIONS TO MEDAREX REPRESENTATIONS AND WARRANTIES. Opposition in the European Patent Office against EP 553244 (European application number 91919595.8) filed by Pasteur Merieux on September 30, 1999.
Sample 1Sample 2
AutoNDA by SimpleDocs
EXCEPTIONS TO MEDAREX REPRESENTATIONS AND WARRANTIES. Opposition in the European Patent Office against EP 553244 (European application number 91919595.8) filed by Pasteur Merieux on September 30, 1999. [ **** ] indicates confidential portions have been redacted and submitted separately pursuant to confidentiality request with the Commission AMENDMENT NO. 1 TO ASSIGNMENT AND LICENSE AGREEMENT THIS AMENDMENT NO. 1 TO ASSIGNMENT AND LICENSE AGREEMENT (“Amendment No. 1”) is made and entered into effective as of October 19, 2007 (“Amendment No. 1 Date”) by and between MEDAREX, INC., 000 Xxxxx Xxxx, Xxxxxxxxx, Xxx Xxxxxx 00000 and GENPHARM INTERNATIONAL, INC., 000 Xxxxxxxxxx Xxxxx, Xxxxxxxx, Xxxxxxxxxx 00000 (collectively, “Medarex”) and CELLDEX THERAPEUTICS, INC., 000 Xxxxxxx Xxxxx, Xxxxx 000, Xxxxxxxxxxxx, Xxx Xxxxxx 00000 (“Celldex”). Capitalized terms used in this Amendment No. 1 that are not otherwise defined herein shall have the same meanings as such terms are defined in the Assignment and License Agreement (as defined below). Celldex and Medarex each may be referred to herein individually as a “Party” or, collectively, as the “Parties”.
Sample 1

Related to EXCEPTIONS TO MEDAREX REPRESENTATIONS AND WARRANTIES

  • Your Representations and Warranties You represent and warrant to the Company that:

  • Investment Representations and Warranties The Purchaser understands and agrees that the offering and sale of the Securities has not been registered under the 1933 Act or any applicable state securities laws and is being made in reliance upon federal and state exemptions for transactions not involving a public offering which depend upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations as expressed herein.

  • Ongoing Representations and Warranties If, at any time during the term of this Agreement, it discovers any fact or omission, or any event or change of circumstances has occurred, which would make any of its representations and warranties herein inaccurate or incomplete in any material respect, it will provide prompt written notification to the Sub-Adviser of such fact, omission, event, or change of circumstance, and the facts related thereto. The Adviser agrees that it will provide prompt notice to the Sub-Adviser in the event that: (i) the Adviser makes an assignment for the benefit of creditors, files a voluntary petition in bankruptcy, or is otherwise adjudged bankrupt or insolvent by a court of competent jurisdiction; or (ii) a material event occurs that could reasonably be expected to adversely impact the Adviser’s ability to perform this Agreement.

  • Buyer Representations and Warranties The Buyer represents and warrants to the Company and Seller that:

  • Company Representations and Warranties The Company represents and warrants to and agrees with each Subscriber that:

  • Continuing representations and warranties The Borrower represents and warrants to the Bank that:

  • Licensor’s Representations and Warranties Licensor represents and warrants to Licensee that:

  • Mutual Representations and Warranties Each Party hereby represents and warrants to the other Party as follows:

  • Covenants, Representations and Warranties The General Partner covenants, represents and warrants that the following are presently true, will be true at the time of each Capital Contribution payment made by the Limited Partner and will be true during the term of this Agreement, to the extent then applicable.

  • Seller Representations and Warranties The Seller represents and warrants to the Purchaser as of the Closing Date:

Time is Money Join Law Insider Premium to draft better contracts faster.